American Vietnamese Biotech Incorporation announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was VND 30,420.113 million compared to VND 124,371.404 million a year ago. Operating income was VND 3,095.289 million compared to VND 56,963.452 million a year ago. Net income was VND 17,950.719 million compared to VND 55,623.194 million a year ago. Basic earnings per share was VND 473 compared to VND 1,761 a year ago. For the nine months, total revenue was VND 128,571.585 million compared to VND 307,013.588 million a year ago. Operating income was VND 60,237.099 million compared to VND 111,433.384 million a year ago. Net income was VND 73,368.458 million compared to VND 108,580.603 million a year ago. Basic earnings per share was VND 1,933 compared to VND 3,714 a year ago.